- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Recently Accepted Articles ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Evidence-Based Complementary and Alternative Medicine
Volume 2013 (2013), Article ID 951758, 7 pages
Identification of a Calcium Signalling Pathway of S--Gingerol in HuH-7 Cells
1Faculty of Pharmacy, University of Sydney, Camperdown, NSW 2006, Australia
2Heart Research Institute, Newtown, NSW 2042, Australia
3Department of Endocrinology, Dezhou People's Hospital, Dezhou, Shandong 253014, China
4School of Medical and Molecular Biosciences, University of Technology Sydney, Ultimo, NSW 2007, Australia
5Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada
6Department of Physiology and Pharmacology, University of Calgary, Calgary, Alberta, Canada T2N 1N4
Received 20 May 2013; Revised 28 June 2013; Accepted 28 June 2013
Academic Editor: Juliano Ferreira
Copyright © 2013 Xiao-Hong Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Calcium signals in hepatocytes control cell growth, proliferation, and death. Members of the transient receptor potential (TRP) cation channel superfamily are candidate calcium influx channels. NFκB activation strictly depends on calcium influx and often induces antiapoptotic genes favouring cell survival. Previously, we reported that S--gingerol is an efficacious agonist of the transient receptor potential cation channel subfamily V member 1 (TRPV1) in neurones. In this study, we tested the effect of S--gingerol on HuH-7 cells using the Fluo-4 calcium assay, RT-qPCR, transient cell transfection, and luciferase measurements. We found that S--gingerol induced a transient rise in in HuH-7 cells. The increase in induced by S--gingerol was abolished by preincubation with EGTA and was also inhibited by the TRPV1 channel antagonist capsazepine. Expression of TRPV1 in HuH-7 cells was confirmed by mRNA analysis as well as a test for increase of by TRPV1 agonist capsaicin and its inhibition by capsazepine. We found that S--gingerol induced rapid NFκB activation through TRPV1 in HuH-7 cells. Furthermore, S--gingerol-induced NFκB activation was dependent on the calcium gradient and TRPV1. The rapid NFκB activation by S--gingerol was associated with an increase in mRNA levels of NFκB-target genes: cIAP-2, XIAP, and Bcl-2 that encode antiapoptotic proteins.
The liver plays a central role in intermediary metabolism, the detoxification of endogenous and exogenous compounds, and whole body homeostasis. The predominant cell type in the liver is the hepatocyte, which comprises about 70% of all cells [1, 2]. Calcium signals in hepatocyte regulate glucose, fatty acid, amino acid, and xenobiotic metabolism. They mediate essential cellular functions, including cell movement, secretion, and gene expression, thereby controlling cell growth, proliferation, and cell death [3–7].
An essential part of the intracellular calcium signal is generated by the influx of extracellular calcium ions, mainly through cation channels with distinctive calcium selectivity. Transient receptor potential (TRP) channels most likely account for most of the receptor-activated calcium permeable channels in hepatocytes, although the molecular identification and function of only a few of the channels have been reasonably well established .
Ginger (Zingiber officinale) is a medicinal plant that has been used in herbal medicine worldwide for a wide array of conditions that include arthritis, rheumatism, toothache, asthma, stroke, nausea, and infectious disease [9, 10]. Its use in inflammatory conditions is consistent with anti-inflammatory properties of its components in vitro and in vivo [11–13].
Phenolic gingerols and related compounds are responsible for the pungency of ginger. Gingerols possess the vanillyl moiety, which is considered important for activation of the TRPV1 expressed in nociceptive sensory neurones . We previously reported that 6-gingerol is a reasonably potent and efficacious agonist of the TRPV1 channel in neurones . To our knowledge, we now report for the first time that the principle component of ginger, S--gingerol, activates the TRPV1 channel in HuH-7 cells to induce a transient rise in intracellular calcium concentration (). This rise is paralleled by a rapid and transient increase in NFκB activation, mediating expression of NFκB-regulated antiapoptotic genes. This study identifies a novel signalling pathway of S--gingerol in hepatocytes.
2. Material and Methods
2.1. Materials and Cell Culture
S--Gingerol (1-[4′-hydroxy-3′-methoxyphenyl]-5-hydroxy-3-decanone) was isolated from total ginger extract as described previously . Based on the previous study in our laboratory, 50 μM and 100 μM of S--gingerol were used in this study (unpublished data). EGTA (Sigma-Aldrich Pty. Ltd., Castle Hill, NSW, Australia) was dissolved in Milli Q water to a concentration of 0.2 M, pH 8.0. Capsaicin and capsazepine (Sigma-Aldrich) were dissolved in DMSO to a concentration of 10 mM. Fluo-4 calcium assay kit (starter pack with buffer) was purchased from Life Technologies Australia Pty Ltd (Victoria, Australia). Poly-D-Lysine 96-well microplates were purchased from BD Biosciences (California, USA). HuH-7 cells (Health Science Research Resources Bank, Osaka, Japan) were cultured in DMEM medium (Sigma-Aldrich, Castle Hill, NSW, Australia) with 10% FBS (Life Technologies Australia Pty. Ltd., Victoria, Australia) at 37°C in 5% CO2.
2.2. Measurement of Levels in HuH-7 Cells Using Fluo-4 Probe
Fluo-4 AM is a fluorescent Ca2+ indicator that is widely used for in-cell measurement of agonist-stimulated and antagonist-inhibited calcium signalling in high-throughput screening applications. In this study, Fluo-4 NW calcium assay kit (starter pack) was used to measure the levels in HuH-7 cells. Briefly, HuH-7 cells were cultured in Poly-D-lysine 96-well plates to near confluence, and the growth medium was removed from the cell cultures. 100 μL of dye loading solution was added quickly to each well. After incubation at 37°C for 30 min, the plate was incubated at room temperature for an additional 30 min. In each experiment HuH-7 cells were exposed to DMSO (as control), S--gingerol, or capsaicin; in inhibition experiments, HuH-7 cells were first exposed to EGTA or capsazepine for 2 min, followed by addition of S--gingerol. Fluo-4 fluorescence was recorded every 2 secs on the NOVOstar system (BMG LABTECH GmbH, Ortenberg, Germany). The Ca2+-dependent fluorescence changes were calibrated by Fluo-4 fluorescence of control at 0 time () to attain . The Ca2+ transients were represented as a ratio of versus time. All experiments were performed at 20–22°C.
2.3. Transient Cell Transfection and Luciferase Measurements
One day before transfection, HuH-7 cells were seeded (2 × 105 cells/well) in a 12-well plate. 0.4 μg NF-κB-luciferase plasmid DNA (Promega Corporation, Madison, WI, USA), 0.08 μg pTK-renilla plasmid DNA (Promega), and Effectene (Qiagen, Melbourne, Australia) were prepared and transfection was performed following the manufacturer’s protocol. After 6 hours incubation, cells were washed twice with 1× PBS followed by a 24-hour incubation. 1 mL fresh medium was then supplemented with S--gingerol (100 μM) or 0.5% DMSO (control). For the inhibitor experiments, transfected cells were preincubated with capsazepine (40 μM) or EGTA (2 mM) for 30 min before incubation with S--gingerol (100 μM). After treatment at different time points, cell lysates were prepared by washing the cells with ice-cold PBS twice, followed by the addition of 100 μL 1× passive lysis buffer (Promega).
To assay for promoter activity, 50 μL luciferase solution (Promega) was automatically injected into 10 μL cell lysate, and luciferase activity was measured as light emission using a luminometer. Stop and Glow reagent (50 μL, Promega) was then added to measure renilla activity (Dual-Luciferase assay, Promega). For each transfection study, luciferase activity was normalized to renilla activity.
Total RNA was extracted from HuH-7 cells using TRI reagent (Sigma-Aldrich) and the concentration was normalized to 100 ng/μL using a Nanoveu reader (LifeSience). cDNA was generated from 100 ng of total RNA using iSCRIPT (Bio-Rad, Reagents Park, NSW, Australia). An aliquot of each cDNA sample (1 μL) was amplified by qPCR in reaction mixtures containing primers (12 pmol each) and iQ SYBR Green Supermix (Bio-Rad). Sequences of the primers used in the qPCR reaction were as follows: human TRPV1 sense: CCT ACA GCA GCA GCG AGA CC, antisense: AGG CAG TAG ACC AGG AAG TTG AAG; human cIAP-2 sense: AGC TGA AGC TGT GTT ATA TGA GC, antisense: ACT GTA CCC TTG ATT GTA CTC CT; human XIAP sense: GAC AGG CCA TCT GAG ACA CAT, antisense: GGG GTT AGG TGA GCA TAG TCT G; human Bcl-2 sense: GAA CTG GGG GAG GAT TGT GG, antisense: CCG GTT CAG GTA CTC AGT CA; human β2-microglobulin (B2M) sense: 5′-CAT CCA GCG TAC TCC AAA GA, antisense: 5′-GAC AAG TCT GAA TGC TCC AC. Amplification was performed in an iQ5 thermocycler (Bio-Rad) using the following protocol: 95°C for 30 secs, Tm of specific primer sets for 30 secs and 72°C for 30 secs. Relative changes in mRNA levels were determined by the ΔΔCT method , using human B2M levels, respectively, as the reference gene.
2.5. Statistical Analysis
Data are expressed as mean ± SEM. Significant differences between control and S--gingerol or capsaicin treatments were determined by unpaired, 2-tail Student’s -test. Differences between two treatments conditions were examined by one-way ANOVA, with Bonferroni’s posttest analysis to determine significance. GraphPad PRISM Software Version 4.03 (GraphPad Software, Inc., San Diego, CA, USA) was used for analyses. Significance was set at .
3.1. S--Gingerol Transiently Increases Levels in HuH-7 Cells
The effect of S--gingerol on levels in HuH-7 cells was determined by Fluo-4 NW calcium assay. Application of 100 μM S--gingerol to cultured HuH-7 cells loaded with Fluo-4 probe increased levels rapidly (Figure 1(a)). The rise in levels was transient, with levels dropping rapidly after 30 secs. The effect of S--gingerol on levels was dose-dependent, with a large increase occurring from 50 μM to 100 μM. To test whether the transient increase was dependent on extracellular Ca2+, 2 mM EGTA was used to chelate extracellular Ca2+. The results show that the rapid increase in levels was totally abolished by EGTA (Figure 1(b)). As S--gingerol was dissolved in DMSO up to a maximum concentration of 0.5% in the assay medium, 0.5% DMSO was used as vehicle control in all experiments. DMSO had no effect on levels (Figures 1(a) and 1(b)). These results demonstrate that the increase in S--gingerol-induced levels required a large Ca2+ gradient for influx of extracellular calcium into HuH7 cells.
3.2. S--Gingerol Affects TRPV1 in HuH-7 Cells
The TRPV1 is a nonselective cation channel  and activation of TRPV1 channel induces influx of calcium. We have previously shown that S--gingerol, by acting as a TRPV1 channel agonist, induces the TRPV1 activation in capsaicin-sensitive neurones and the activation is blocked by the TRPV1 channel antagonist, capsazepine . To test for TRPV1 channel activity in HuH-7 cells, we first investigated the expression of TRPV1in HuH-7 cells. Exposure of HuH-7 cells to the TRPV1 channel agonist capsaicin (10 μM) caused a significant increase in the mRNA levels of TRPV1 (Figure 2(a)). We also showed that application of 10 μM capsaicin to cultured HuH-7 cells loaded with Fluo-4 probe increased levels (Figure 2(b)). The increase in levels by capsaicin was markedly inhibited by TRPV1 channel antagonist capsazepine (40 μM) (Figure 2(b)). These data indicate that HuH-7 cells express the TRPV1 channel.
We then examined if S--gingerol affected TRPV1 channels in HuH-7 cells. Exposure of HuH-7 cells to 100 μM S--gingerol induced a transient spike which was blocked by the TRPV1 channel antagonist capsazepine (40 μM) in HuH-7 cells loaded with Fluo-4 (Figure 2(b)). These results suggest that S--gingerol exhibits agonist activity towards TRPV1 channel in HuH-7 cells.
3.3. TRPV1 Is Involved in S--Gingerol-Mediated Increase in NFκB Activation in HuH-7 Cells
Intracellular Ca2+ signals a number of different regulatory pathways in vitro. One important pathway is the proinflammatory NFκB pathway. Under basal conditions, NFκB is present in the cell cytoplasm bound to the NFκB inhibitory protein, inhibitor kappa B (IκB). Upon exposure to proinflammatory stimuli, NFκB is free to migrate to the cell nucleus to function as a transcription factor, activating expression of target genes. To test the effects of -S-gingerol on the activation of NFκB, HuH-7 cells were transfected with an NFκB-luciferase reporter vector. Expression of the luciferase gene is controlled by a synthetic promoter that contains direct repeats of the transcription recognition sequences for the binding sites of nuclear factor κB (NFκB). When this luciferase reporter vector is transfected into mammalian cells, the activation of endogenous protein kinases initiated by the stimulation will result in the activation of corresponding transactivators which in turn stimulate luciferase expression. Transfectants were then exposed to 100 μM S--gingerol for 7.5, 15, 30, 60, or 120 min. NFκB activation was increased within 7.5 min of exposure to S--gingerol and reached a peak by 15 min (Figure 3(a)). This time course is more rapid than the classical S--gingerol-mediated genomic response . After a longer incubation time of 30 min with S--gingerol, NFκB activation started to decline and it switched off by 120 min.
To investigate whether the transient increase in NFκB activation by S--gingerol is due to calcium influx via TRPV1 channel, HuH7 cells transfected with an NFκB-luciferase reporter vector were preexposed to TRPV1 antagonist capsazepine (40 μM) (Figure 3(b)) or EGTA (2 mM) (Figure 3(c)), respectively, then incubated with 100 μM S--gingerol for 7.5, 15, 30, 60, or 120 min. Preexposure to capsazepine or EGTA completely blocked the -S-gingerol-induced NFκB activation to baseline levels measured with DMSO (Figures 3(b) and 3(c)). These results indicate that the TRPV1 channel and a calcium gradient are involved in -S-gingerol induced NFκB activation in HuH-7 cells.
3.4. TRPV1 Is Involved in S--Gingerol-Induced Expression of cIAP-2, XIAP, and Bcl-2 in HuH-7 Cells
Activated NFκB has antiapoptotic action through the regulation of gene expression for antiapoptotic genes. Several genes that may play a role in blocking apoptosis and whose expression is regulated by NFκB have been identified. These include inhibitors of apoptosis family (IAP) and the Bcl-2 family, with cIAP-2, XIAP, and Bcl-2 being the best studied [20, 21]. HuH-7 cells were tested for whether S--gingerol regulated antiapoptotic gene expression. The mRNA levels of cIAP-2, XIAP, and Bcl-2 were detected by RT-qPCR. Figure 4 shows that the mRNA levels of cIAP-2 (a), XIAP (b), and Bcl-2 (c) were significantly increased by %, %, and %, respectively, after 100 μM S--gingerol treatment for 1 hour.
To investigate whether TRPV1 channel is involved in the increased expression of cIAP-2, XIAP, and Bcl-2 induced by S--gingerol, HuH7 cells were preexposed to TRPV1 antagonist capsazepine (40 μM) and then incubated with 100 S--gingerol. Figure 4 shows that compared to HuH-7 cells incubated with S--gingerol alone, when HuH-7 cells were preincubated with 40 μM capsazepine, the S--gingerol-induced increase in cIAP-2 (A), XIAP (B), and Bcl-2 (C) expression was completely abrogated, with levels below baseline, and this correlated with the attenuation of NFκB activation (Figure 3(b)). The mRNA levels of cIAP-2, XIAP, and Bcl-2 were significantly decreased by %, %, and %, respectively. These results suggest that TRPV1 channel is involved in regulating the S--gingerol-induced expression of antiapoptotic genes in HuH-7 cells.
The most prominent finding of this study is that S--gingerol, the major component in Zingiber officinale (ginger), is able to rapidly induce a transient rise in in HuH-7 cells via the TRPV1 ion channel. This regulates a rapid increase in NFκB activation that, in turn, is associated with an increase in the expression of the NFκB-regulated genes, cIAP-2, XIAP, and Bcl-2. This study provides evidence for a novel signalling pathway of S--gingerol in HuH-7 cells that may be associated with hepatocyte survival.
Our study showed that HuH-7 cells express the TRPV1 channel. This result is in keeping with previous studies which have measured a capsaicin-induced increase in TRPV1 mRNA levels in neurons  and vascular smooth muscle cells . We extend the finding to show that the TRPV1 channel produced a rapid Ca2+ increase that was mediated by the TRPV1 selective agonist capsaicin. This demonstrates that the TRPV1 is a functional Ca2+ entry channel in HuH-7 cells. We used EGTA to chelate extracellular Ca2+ which completely abrogated the S--gingerol response that is in accordance to the Ca2+ influx mechanism previously described for MDCK renal tubular cells . We then showed that S--gingerol can induce Ca2+ influx in HuH-7 cells through TRPV1 in similar fashion to that which we have previously shown for sensory neurons from rat DRGs . Together, this study provides new evidence for a novel signalling pathway by S--gingerol in hepatocytes through which physiology can be modulated.
We investigated NFκB activation as a pathway by which S--gingerol could modulate cell physiology. NFκB is a transcription factor, central to orchestrating inflammatory response in cells when activated chronically, but which is also involved in antiapoptotic regulation when activated transiently and subacutely. Long-term S--gingerol exposure (>4 hours) has demonstrated anti-inflammatory and antioxidant effects through inhibiting enhanced NFκB activation by inflammatory mediators [19, 25–28], consistent with an anti-inflammatory role of S--gingerol through attenuation of chronic NFκB activation. An important finding arising from the present study is that short-term exposure of HuH-7 cells to S--gingerol transiently activates NFκB, leading to increased expression of target antiapoptotic genes. Taken together, S--gingerol is shown to exhibit potential cellular protective benefits through transient activation of NFκB initially, which may then be followed by long-term suppression of chronic NFκB activation.
NFκB exerts antiapoptotic effects by increasing expression of antiapoptotic genes, including those in the Bcl-2 family and IAP family, such as Bcl-2, cIAP-2, and XIAP [20, 21]. Bcl-2 is one of the major antiapoptotic members of the Bcl-2 family, which protect cells by decreasing the permeability of the mitochondrial membrane [29, 30]. cIAP-2 and XIAP potently suppress apoptosis by directly inhibiting caspase-3, caspase-7, and caspase-9 activity [31, 32]. HuH-7 cells have been used for investigating the differential signalling involved in cell survival by selenium and TGF-β1-induced apoptosis [33, 34]. Our present studies in HuH-7 cells show that Bcl-2, cIAP-2, and XIAP mRNA levels are increased by S--gingerol. The increase is consistent with rapid NFκB activation, suggesting that S--gingerol can enhance hepatocyte cell survival against inflammatory insults.
In conclusion, S--gingerol activates NFκB via a mechanism that involves a transient increase in hepatocytes. The transient increase in is via the activation of TRPV1 channels. Together, the results provide evidence for the presence of TRPV1 channels in HuH-7 cells and demonstrate that this channel is responsive to S--gingerol, a major component of ginger. Importantly, S--gingerol through the TRPV1--NFκB pathway activates expression of antiapoptotic genes. Thus, our study provides evidence that S--gingerol is a potent cellular protective component of ginger that may be used potentially as a therapeutic agent against inflammation of hepatocytes.
Conflict of Interests
There is no conflict of interests for any author.
- B. Young, “Liver and pancreas,” in Wheater's Functional Histology, pp. 274–275, Churchill Livingstone, Edinbrugh, UK, 4th edition, 2000.
- F. F. Mohammed and R. Khokha, “Thinking outside the cell: proteases regulate hepatocyte division,” Trends in Cell Biology, vol. 15, no. 10, pp. 555–563, 2005.
- J. L. Boyer, “Bile formation and cholestasis,” in Schiffs Disease of the Liver, pp. 135–165, Lippincott, Williams & Wilkins, Philadelphia, Pa, USA, 9th edition, 2002.
- M. F. Leite and M. Nathanson, “Calcium signaling in the hepatocyte,” in The Liver: Biology and Pathobiology, pp. 537–554, Lippincoot, William & Wilkins, Philadelphia, Pa, USA, 2001.
- C. J. Dixon, P. J. White, J. F. Hall, S. Kingston, and M. R. Boarder, “Regulation of human hepatocytes by P2Y receptors: control of glycogen phosphorylase, Ca2+, and mitogen-activated protein kinases,” Journal of Pharmacology and Experimental Therapeutics, vol. 313, no. 3, pp. 1305–1313, 2005.
- E. M. O'Brien, D. A. Gomes, S. Sehgal, and M. H. Nathanson, “Hormonal regulation of nuclear permeability,” Journal of Biological Chemistry, vol. 282, no. 6, pp. 4210–4217, 2007.
- V. B. Nieuwenhuijs, M. T. D. Bruijn, R. T. A. Padbury, and G. J. Barritt, “Hepatic ischemia-reperfusion injury: roles of Ca2+ and other intracellular mediators of impaired bile flow and hepatocyte damage,” Digestive Diseases and Sciences, vol. 51, no. 6, pp. 1087–1102, 2006.
- G. J. Barritt, J. Chen, and G. Y. Rychkov, “Ca2+-permeable channels in the hepatocyte plasma membrane and their roles in hepatocyte physiology,” Biochimica et Biophysica Acta, vol. 1783, no. 5, pp. 651–672, 2008.
- L. C. Tapsell, I. Hemphill, L. Cobiac et al., “Health benefits of herbs and spices: the past, the present, the future,” Medical Journal of Australia, vol. 185, no. 4, pp. S1–S24, 2006.
- W.-H. Wang and Z.-M. Wang, “Studies of commonly used traditional medicine-ginger,” Zhongguo Zhongyao Zazhi, vol. 30, no. 20, pp. 1569–1573, 2005.
- N. Mascolo, R. Jain, S. C. Jain, and F. Capasso, “Ethnopharmacologic investigation of ginger (Zingiber officinale),” Journal of Ethnopharmacology, vol. 27, no. 1-2, pp. 129–140, 1989.
- X.-H. Li, K. C.-Y. McGrath, S. Nammi, A. K. Heather, and B. D. Roufogalis, “Attenuation of liver pro-inflammatory responses by Zingiber officinale via inhibition of NF-kappa B activation in high-fat diet-fed rats,” Basic and Clinical Pharmacology and Toxicology, vol. 110, no. 3, pp. 238–244, 2012.
- F. Kiuchi, M. Shibuya, and U. Sankawa, “Inhibitors of prostaglandin biosynthesis from ginger,” Chemical and Pharmaceutical Bulletin, vol. 30, no. 2, pp. 754–757, 1982.
- C. S. J. Walpole, R. Wrigglesworth, S. Bevan et al., “Analogues of capsaicin with agonist activity as novel analgesic agents; structure-activity studies. 1. The aromatic ‘A-region’,” Journal of Medicinal Chemistry, vol. 36, no. 16, pp. 2362–2372, 1993.
- V. N. Dedov, V. H. Tran, C. C. Duke et al., “Gingerols: a novel class of vanilloid receptor (VR1) agonists,” British Journal of Pharmacology, vol. 137, no. 6, pp. 793–798, 2002.
- Y. Li, V. H. Tran, C. C. Duke, and B. D. Roufogalis, “Gingerols of Zingiber officinale enhance glucose uptake by increasing cell surface GLUT4 in cultured L6 myotubes,” Planta Medica, vol. 78, no. 14, pp. 1549–1555, 2012.
- S. A. Bustin, “Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays,” Journal of Molecular Endocrinology, vol. 25, no. 2, pp. 169–193, 2000.
- M. J. Caterina, M. A. Schumacher, M. Tominaga, T. A. Rosen, J. D. Levine, and D. Julius, “The capsaicin receptor: a heat-activated ion channel in the pain pathway,” Nature, vol. 389, no. 6653, pp. 816–824, 1997.
- J.-K. Kim, Y. Kim, K.-M. Na, Y.-J. Surh, and T.-Y. Kim, “-gingerol prevents UVB-induced ROS production and COX-2 expression in vitro and in vivo,” Free Radical Research, vol. 41, no. 5, pp. 603–614, 2007.
- M. Karin and A. Lin, “NF-kappaB at the crossroads of life and death,” Nature Immunology, vol. 3, no. 3, pp. 221–227, 2002.
- S. Shishodia and B. B. Aggarwal, “Nuclear factor-κB activation: a question of life or death,” Journal of Biochemistry and Molecular Biology, vol. 35, no. 1, pp. 28–40, 2002.
- X. Xu, P. Wang, X. Zou, D. Li, L. Fang, and Q. Lin, “Increases in transient receptor potential vanilloid-1 mRNA and protein in primary afferent neurons stimulated by protein kinase C and their possible role in neurogenic inflammation,” Journal of Neuroscience Research, vol. 87, no. 2, pp. 482–494, 2009.
- L. Ma, J. Zhong, Z. Zhao et al., “Activation of TRPV1 reduces vascular lipid accumulation and attenuates atherosclerosis,” Cardiovascular Research, vol. 92, no. 3, pp. 504–513, 2011.
- C.-Y. Chen, C.-H. Chen, C.-H. Kung, S.-H. Kuo, and S.-Y. Kuo, “-gingerol induces Ca2+ mobilization in Madin-Darby canine kidney cells,” Journal of Natural Products, vol. 71, no. 1, pp. 137–140, 2008.
- T.-Y. Lee, K.-C. Lee, S.-Y. Chen, and H.-H. Chang, “6-Gingerol inhibits ROS and iNOS through the suppression of PKC-α and NF-κB pathways in lipopolysaccharide-stimulated mouse macrophages,” Biochemical and Biophysical Research Communications, vol. 382, no. 1, pp. 134–139, 2009.
- S. Tripathi, K. G. Maier, D. Bruch, and D. S. Kittur, “Effect of 6-gingerol on pro-inflammatory cytokine production and costimulatory molecule expression in murine peritoneal macrophages,” Journal of Surgical Research, vol. 138, no. 2, pp. 209–213, 2007.
- S. O. Kim, J. K. Kundu, Y. K. Shin et al., “-Gingerol inhibits COX-2 expression by blocking the activation of p38 MAP kinase and NF-κB in phorbol ester-stimulated mouse skin,” Oncogene, vol. 24, no. 15, pp. 2558–2567, 2005.
- S. O. Kim, K.-S. Chun, J. K. Kundu, and Y.-J. Surh, “Inhibitory effects of -gingerol on PMA-induced COX-2 expression and activation of NF-kappaB and p38 MAPK in mouse skin,” BioFactors, vol. 21, no. 1–4, pp. 27–31, 2004.
- J. M. Adams and S. Cory, “The Bcl-2 protein family: arbiters of cell survival,” Science, vol. 281, no. 5381, pp. 1322–1326, 1998.
- S. Cory and J. M. Adams, “The BCL2 family: regulators of the cellular life-or-death switch,” Nature Reviews Cancer, vol. 2, no. 9, pp. 647–656, 2002.
- Q. L. Deveraux and J. C. Reed, “IAP family proteins: suppressors of apoptosis,” Genes and Development, vol. 13, no. 3, pp. 239–252, 1999.
- I. Tamm, Y. Wang, E. Sausville et al., “IAP-family protein Survivin inhibits caspase activity and apoptosis induced by Fas (CD95), bax, caspases, and anticancer drugs,” Cancer Research, vol. 58, no. 23, pp. 5315–5320, 1998.
- Y.-C. Lee, Y.-C. Tang, Y.-H. Chen, C.-M. Wong, and A.-P. Tsou, “Selenite-induced survival of HuH7 hepatoma cells involves activation of focal adhesion kinase-phosphatidylinositol 3-kinase-Akt pathway and Rac1,” Journal of Biological Chemistry, vol. 278, no. 41, pp. 39615–39624, 2003.
- G. Fan, X. Ma, B. T. Kren, and C. J. Steer, “Unbound E2F modulates TGF-β1-induced apoptosis in HuH-7 cells,” Journal of Cell Science, vol. 115, no. 15, pp. 3181–3191, 2002.